Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.
about
Trial watch: Dendritic cell-based anticancer therapyCD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.Immunomonitoring in glioma immunotherapy: current status and future perspectives.Dendritic cell vaccines: A review of recent developments and their potential pediatric application.Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial.Immunosuppressive CD14+HLA-DRlo/neg monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes.A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
P2860
Q27024047-6348FA14-BA5E-43F1-8294-435FED894184Q34976095-4DD54CF9-297A-40A8-ADD5-ADADB4D29FBAQ35799695-D65E6E6A-DE4B-4DC2-8D5B-6E13F8A64DC2Q38261273-EB4BECF7-5C35-487C-88A3-C27EA8D343E1Q38659771-63340F06-CA8F-4614-9D32-9A41113D961CQ38849396-F6BD7DFC-9F97-4BA6-A51C-D9D1FA5206E4Q39532047-D48996AB-91EE-461F-88AC-EBBC1E18A497Q41733152-E619ABC5-DE68-4720-A8E8-7065B24441F5Q43090726-A1A4F449-FE8C-4771-9CF9-223E8A824B4DQ54980235-D90FDA9A-6734-4C93-832B-739B310A6EA0Q57486475-C9BD10A3-A8D9-4539-8C94-7AE06A3EBB0F
P2860
Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vaccination with dendritic cel ...... uces a CD4(+)IL17(+) response.
@ast
Vaccination with dendritic cel ...... uces a CD4(+)IL17(+) response.
@en
type
label
Vaccination with dendritic cel ...... uces a CD4(+)IL17(+) response.
@ast
Vaccination with dendritic cel ...... uces a CD4(+)IL17(+) response.
@en
prefLabel
Vaccination with dendritic cel ...... uces a CD4(+)IL17(+) response.
@ast
Vaccination with dendritic cel ...... uces a CD4(+)IL17(+) response.
@en
P2093
P2860
P50
P356
P1476
Vaccination with dendritic cel ...... uces a CD4(+)IL17(+) response.
@en
P2093
Christopher Moertel
David H McKenna
H Brent Clark
John R Ohlfest
Michael P Gustafson
Michael R Olin
Tambra Dahlheimer
Walter Low
P2860
P2888
P356
10.1186/2051-1426-2-4
P577
2014-02-18T00:00:00Z
P5875
P6179
1012408385